| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial
|
Xu, Bo
|
|
|
398 |
10317 |
p. 2149-2159
|
artikel
|
| 2 |
Angiography-derived quantitative flow ratio guidance of coronary intervention: measure twice, cut once
|
Byrne, Robert A
|
|
|
398 |
10317 |
p. 2130-2131
|
artikel
|
| 3 |
Clay
|
Guglani, Sam
|
|
|
398 |
10317 |
p. 2144
|
artikel
|
| 4 |
Department of Error
|
|
|
|
398 |
10317 |
p. 2148
|
artikel
|
| 5 |
Department of Error
|
|
|
|
398 |
10317 |
p. 2148
|
artikel
|
| 6 |
Department of Error
|
|
|
|
398 |
10317 |
p. 2148
|
artikel
|
| 7 |
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
|
Ella, Raches
|
|
|
398 |
10317 |
p. 2173-2184
|
artikel
|
| 8 |
High-dose budesonide for early COVID-19
|
Lipworth, Brian
|
|
|
398 |
10317 |
p. 2147
|
artikel
|
| 9 |
High-dose budesonide for early COVID-19
|
Berezowski, Ivan
|
|
|
398 |
10317 |
p. 2146-2147
|
artikel
|
| 10 |
High-dose budesonide for early COVID-19 – Authors' reply
|
Hobbs, F D Richard
|
|
|
398 |
10317 |
p. 2147-2148
|
artikel
|
| 11 |
Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19
|
Li, Jing-Xin
|
|
|
398 |
10317 |
p. 2134-2135
|
artikel
|
| 12 |
Long-acting amylin analogue for weight reduction
|
Gadde, Kishore M
|
|
|
398 |
10317 |
p. 2132-2134
|
artikel
|
| 13 |
Offline: The origin story
|
Horton, Richard
|
|
|
398 |
10317 |
p. 2136
|
artikel
|
| 14 |
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
|
Karim, Salim S Abdool
|
|
|
398 |
10317 |
p. 2126-2128
|
artikel
|
| 15 |
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
|
Lau, David C W
|
|
|
398 |
10317 |
p. 2160-2172
|
artikel
|
| 16 |
Oncogenic NTRK fusion in congenital spinal cord glioblastoma: sequencing directs treatment
|
Andrews, John Paul
|
|
|
398 |
10317 |
p. 2185
|
artikel
|
| 17 |
Preventing violence against women: beyond 16 days
|
The Lancet,
|
|
|
398 |
10317 |
p. 2125
|
artikel
|
| 18 |
Prioritising immunisation across the life course
|
Saso, Anja
|
|
|
398 |
10317 |
p. 2145
|
artikel
|
| 19 |
Prioritising immunisation across the life course – Authors' reply
|
Mosser, Jonathan F
|
|
|
398 |
10317 |
p. 2145-2146
|
artikel
|
| 20 |
Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
|
Omer, Saad B
|
|
|
398 |
10317 |
p. 2186-2192
|
artikel
|
| 21 |
Something in the water
|
Ginn, Stephen
|
|
|
398 |
10317 |
p. e18
|
artikel
|
| 22 |
The evolution of the Italian National Health Service
|
Ricciardi, Walter
|
|
|
398 |
10317 |
p. 2193-2206
|
artikel
|
| 23 |
The healer as the enemy: attacking health care in war
|
Jabbour, Samer
|
|
|
398 |
10317 |
p. 2141-2142
|
artikel
|
| 24 |
Tokyo Nutrition for Growth Summit 2021: an opportunity to accelerate the efforts towards achieving the SDGs
|
Hayashi, Yoshimasa
|
|
|
398 |
10317 |
p. 2128-2130
|
artikel
|
| 25 |
US Supreme Court expected to weaken abortion rights
|
Jaffe, Susan
|
|
|
398 |
10317 |
p. 2137-2138
|
artikel
|
| 26 |
What next for the Philippines’ war on drugs?
|
Burki, Talha
|
|
|
398 |
10317 |
p. 2139-2140
|
artikel
|
| 27 |
Zarlasht Halaimzai: striving to provide a better future for refugees
|
Samarasekera, Udani
|
|
|
398 |
10317 |
p. 2143
|
artikel
|
Tijdschrift beschrijving